Larimar Therapeutics Inc
LRMR
Get informed when a big investor buys or sells
+ FollowMarket Cap$277.37M
Close$
$1.12
44% downside
Current Fair Value
44% downsideOvervalued by 44% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $277.37 Million |
|---|---|
| Enterprise Value | $189.64 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.27 |
| Beta | 0.69 |
| Outstanding Shares | 103,882,937 |
Return
| Return on Equity | -135.50% |
|---|---|
| Return on Assets | -104.42% |
| Return on Invested Capital | -135.29% |
Valuation & Multiples
| P/E Ratio | -1.34 |
|---|---|
| PEG | -5.32 |
| Price to Sales | - |
| Price to Book Ratio | 1.99 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.07 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.39
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 2.0735▲ 142.57% |
|---|---|
| Total Calls | 379,400▼ 20.46% |
| Total Puts | 786,700▲ 154.60% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.37%▼ 10.65% |
|---|---|
| Total Invested | $293.33M▼ 25.70% |
| Investors Holding | 171▲ 1.00% |
ESG Score
No data